We investigated,for the first time in the epidemiological setting, the evidence linking p53 and MDM2 with HIV,as well aspotential implications of SNPs in the p53 pathway for HPV-related outcomes others than cancer development and/or progression. This evidence concerns the gene MDM2 and cancer.